Kidney dialysis is a process that is carried outside of the body that removes waste from the body and keeps a safe and regulated levels of sodium, potassium, and other necessary chemicals and minerals. Dialysis is commonly referred to patients who are suffering from long terms kidney diseases. It is also often prescribed to patients diagnosed with end stage renal disorder (ESRD). Dialysis is generally carried out in clinics and hospitals. There are also some dedicated dialysis centers and at times it can be even done at home. It is projected that the global kidney dialysis equipment market will reach a valuation worth US$22, 917.7 Mn by the end of 2026.
Increasing Prevalence of CKD to Help Market Development
Chronic kidney disease or CKD is a huge risk factor for different disorders such as aging, glomerulonephritis, hypertension, diabetes, and cardiovascular disorders among others. CKD may cause injury to patient’s kidney or at times may result in complete loss of kidney function. This thus leads to the requirement of renal replacement therapy. On the World Kidney Day in 2017, a global awareness campaign was launched. It predicted that nearly 10% of the global population was suffering from chronic kidney disease. Such high number of consumer base is thus a key driving factor for the development of the global kidney dialysis equipment market. In addition to this, the global market for kidney dialysis equipment is also driven by growing geriatric population across the globe. Furthermore, growing preference to kidney dialysis over renal replacement and technological developments are some of the other key factors that are helping to drive the growth of the global kidney dialysis equipment market.
To Get an Exhaustive Overview about the Competition in Kidney Dialysis Equipment Market, Request for a Report Brochure at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39359
Some of the key companies operating in the global kidney dialysis market are Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, NxStage Medical, Inc., and HEMOCLEAN CO., LTD. These players adopt organic and in-organic growth strategies in order to expand their product offerings, strengthen geographical reach, increase customer base, and capture market share.